Post Cardiac Arrest Syndrome
10
2
3
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 10 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 4 completed trials
Clinical Trials (10)
Hypothermia Versus Normothermia After Extracorporeal Cardiopulmonary Resuscitation for Out-of-hospital Cardiac Arrest
Survival After Cardiac Arrest: How New Treatment Guidelines Changed Patient Outcomes.
TNF-α Antagonists Mitigate Systemic Inflammatory Response After Cardiac Arrest.
Intensive Care Unit Management After Cardiac ARrest in Russia
Lung-cOnservative Liquid VEntilation for the Induction of Ultra-Rapid COOLing After Cardiac Arrest
Steroid Treatment After Resuscitated Out-of-Hospital Cardiac Arrest
Post-Surgery Extracorporeal Life Support
Pre-hospital Post ROSC Care: Are we Achieving Our Targets?
Histones and Free-plasma DNA After Cardiac Arrest
The Complement Lectin Pathway After Cardiac Arrest